Short-term efficacy and safety of percutaneous ultrasound-guided pseudomonas aeruginosa-mannose sensitive hemagglutinin injection in postoperative chyle fistula: a cohort study - Scorecard - MDSpire

Short-term efficacy and safety of percutaneous ultrasound-guided pseudomonas aeruginosa-mannose sensitive hemagglutinin injection in postoperative chyle fistula: a cohort study

  • By

  • Yuhan Chen

  • Shouyi Yan

  • Tenghong Liu

  • Wenxin Zhao

  • May 18, 2026

  • 0 min

Share

Clinical Scorecard: Short-term assessment of safety and effectiveness of ultrasound-guided PA-MSHA injection for managing postoperative chyle fistula: A cohort analysis

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with papillary thyroid carcinoma post-total thyroidectomy and neck dissection, particularly high-risk individuals.
Care Setting

Key Highlights

  • Include specific percentage reduction in chyle output within 24-48 hours.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider PA-MSHA injection for high-output chyle fistula when conservative management fails, detailing specific conservative strategies.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Clarify criteria for PA-MSHA injection consideration.

        Clinical Best Practices

        • Expand on conservative management strategies prior to PA-MSHA.

        Related Resources & Content

        Original Source(s)

        Related Content